A detailed history of Financial Architects, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Architects, Inc holds 23,278 shares of ABBV stock, worth $4.19 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
23,278
Previous 23,550 1.15%
Holding current value
$4.19 Million
Previous $3.75 Million 16.44%
% of portfolio
0.48%
Previous 0.61%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $36,042 - $44,852
-272 Reduced 1.15%
23,278 $3.14 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $66,520 - $76,608
-460 Reduced 1.92%
23,550 $3.75 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $9,128 - $10,947
66 Added 0.28%
24,010 $3.88 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $7,515 - $8,620
-56 Reduced 0.23%
23,944 $3.21 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $205,329 - $261,040
-1,492 Reduced 5.85%
24,000 $3.68 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $134,091 - $166,370
1,016 Added 4.15%
25,492 $4.13 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $92,926 - $117,579
865 Added 3.66%
24,476 $3.31 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $36,282 - $41,185
341 Added 1.47%
23,611 $2.55 Million
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $12,940 - $14,416
-123 Reduced 0.53%
23,270 $2.62 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $29,155 - $32,096
285 Added 1.23%
23,393 $2.53 Million
Q4 2020

Feb 17, 2021

SELL
$80.49 - $108.67 $21,812 - $29,449
-271 Reduced 1.16%
23,108 $2.48 Million
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $149,827 - $175,847
1,744 Added 8.06%
23,379 $2.05 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $232,729 - $311,426
3,172 Added 17.18%
21,635 $2.12 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $12,448 - $18,873
-193 Reduced 1.03%
18,463 $1.41 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $65,998 - $82,578
-915 Reduced 4.68%
18,656 $1.65 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $91,761 - $110,324
-1,457 Reduced 6.93%
19,571 $1.48 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $24,768 - $31,660
-377 Reduced 1.76%
21,028 $1.53 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $1.59 Million - $1.87 Million
20,554 Added 2415.28%
21,405 $1.73 Million
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $1.75 Million - $2.06 Million
-22,720 Reduced 96.39%
851 $69,000
Q4 2018

Feb 01, 2019

SELL
$77.85 - $96.01 $92,174 - $113,675
-1,184 Reduced 4.78%
23,571 $2.17 Million
Q3 2018

Oct 29, 2018

SELL
$88.91 - $98.84 $71,128 - $79,072
-800 Reduced 3.13%
24,755 $2.34 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $82,148 - $97,200
-915 Reduced 3.46%
25,555 $2.37 Million
Q1 2018

Apr 23, 2018

BUY
$92.01 - $123.21 $34,871 - $46,696
379 Added 1.45%
26,470 $2.51 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $83,917 - $92,022
-937 Reduced 3.47%
26,091 $2.52 Million
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $1.79 Million - $2.29 Million
25,641 Added 1848.67%
27,028 $2.4 Million
Q3 2017

Oct 23, 2017

BUY
$69.85 - $89.22 $96,881 - $123,748
1,387
1,387 $123,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.